Study type

Study topic

DiseaseĀ /health condition
Human medicinal product

Study type

Non-interventional study

Scope of the study

Drug utilisation

Data collection methods

Secondary use of data
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medical condition to be studied

Chronic obstructive pulmonary disease
Population studied

Short description of the study population

Patients hospitalized for Chronic obstructive pulmonary disease (COPD) and aged 45 and over.

Age groups

Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Special population of interest

Other

Special population of interest, other

Chronic obstructive pulmonary disease (COPD) patients

Estimated number of subjects

3089
Study design details

Main study objective

To compare dual and triple therapies after COPD hospitalizations, on exacerbations, healthcare resource use, costs and persistence.

Outcomes

exacerbations, Hospitalization MedicationsVisits to physicians Medical acts

Data analysis plan

1:1 matching of the 2 cohortsMatching variables were the following:o Inclusion yearo Time between inclusion date and index date (+/- 5 days)o Incidence or not at the combination of dual or triple therapies.o Propensity scorePropensity score was calculated using a logistic regression model estimating the probability to be treated with a triple therapy, using the following confounding factors calculated in the 12 months before index date: o Age at inclusion dateo Gendero CMU-Co Number of COPD treatmentso Number of exacerbationso Number of visits to a general practitionero Number of visits to a respiratory physiciano Presence/absence of the following comorbidities: cardiovascular diseases, depression, cancer and diabeteso Use or non-use of oxygen therapyo Use or non-use of non-invasive ventilationComparison using a Wilcoxon test for matched data